相似文献
1
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.拉贝洛尔治疗高血压患者心绞痛的开放性评估。
Br J Clin Pharmacol. 1979;8(Suppl 2):205S-209S.
2
Beneficial effect of labetalol in hypertensive patients with angina pectoris.
S Afr Med J. 1983 Jan 15;63(3):67-71.
3
[Trial of labetalol in effort angina pectoris].
Ann Cardiol Angeiol (Paris). 1985 Mar;34(3):171-6.
4
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
Br J Clin Pharmacol. 1979 Apr;8 Suppl 2:205S-9S. doi: 10.1111/j.1365-2125.1979.tb04782.x.
5
[Influence of labetalol on the exercise tolerance test in patients with angina pectoris].[拉贝洛尔对心绞痛患者运动耐量试验的影响]
Boll Soc Ital Cardiol. 1978;23(1):281-97.
6
A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.拉贝洛尔与苄乙胍对轻度高血压患者潜在协同作用的比较与研究。
Br J Clin Pharmacol. 1979;8(Suppl 2):183S-187S.
7
8
Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.拉贝洛尔单药治疗肾功能正常和受损的高血压患者。
Br J Clin Pharmacol. 1979;8(Suppl 2):129S-133S.
9
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.硝苯地平或拉贝洛尔在伴有心绞痛的高血压治疗中作为β受体阻滞剂替代药物的作用
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):115S-122S. doi: 10.1111/j.1365-2125.1982.tb01899.x.
10
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience.
Am Heart J. 1980 Mar;99(3):388-96. doi: 10.1016/0002-8703(80)90354-3.
引用本文的文献
1
Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.普萘洛尔和拉贝洛尔对冠心病血流动力学剂量反应的比较效应
Br Heart J. 1982 Oct;48(4):364-71. doi: 10.1136/hrt.48.4.364.
2
Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.硝苯地平或拉贝洛尔在伴有心绞痛的高血压治疗中作为β受体阻滞剂替代药物的作用
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):115S-122S. doi: 10.1111/j.1365-2125.1982.tb01899.x.
3
Diazoxide and labetalol in acute hypertension during haemodialysis.血液透析期间急性高血压时使用二氮嗪和拉贝洛尔。
Eur J Clin Pharmacol. 1983;25(4):523-7. doi: 10.1007/BF00542122.
4
Alpha- and beta-blockade in angina pectoris.心绞痛中的α和β受体阻滞剂
Drugs. 1984;28 Suppl 2:69-87. doi: 10.2165/00003495-198400282-00006.
5
Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.血管舒张在拉贝洛尔降压及抗心绞痛作用中的作用：对合并高血压和心绞痛治疗的启示
Cardiovasc Drugs Ther. 1988 Sep;2(3):369-76. doi: 10.1007/BF00054645.
6
Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.拉贝洛尔，一种α和β肾上腺素能受体阻滞剂：其在治疗中的应用。研讨会综述。
Br J Clin Pharmacol. 1979;8(Suppl 2):239S-244S.
本文引用的文献
1
Closing remarks: current status of labetalol.
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):823-4.
2
Pharmacological effects of labetalol in man.拉贝洛尔对人体的药理作用。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):721-3.
3
Reflex increase in coronary vascular resistance in patients with ischemic heart disease.缺血性心脏病患者冠状动脉血管阻力的反射性增加。
N Engl J Med. 1976 Dec 9;295(24):1333-7. doi: 10.1056/NEJM197612092952401.
Zotero 插件